Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

NCT00608907

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Hematology Institute - Davidoff Center - Rabin Medical Center Petah Tikva, Israel

Divisione di Ematologia - Ospedale S Eugenio - P. le dell'Umanesimo Rome, Italy

Medical Academy - Dept of Hematology and Transplantology Gdansk, Poland

Klinika Nowotworow Ukladu - Chlonnego - Centrum Onkologii - Instytut Warsaw, Poland

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

NCT00144703

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Graft vs Host Disease, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

NCT00144677

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +28 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

Brown Fat Activity and White Fat Accumulation

NCT01517581

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkins Lymphoma, +9 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

View Trial Details

Completed

Ready to Use Supplementary Food in Moderate Childhood Malnutrition

NCT01147198

Conditions: Body Weight, Body Weight Changes, Cachexia, +18 more
Locations: Health Centers run by MSF and MOH Bo, Sierra Leone

View Trial Details

Completed

Allogeneic Blood Stem Cell Transplantation

NCT00423709

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: U.T. M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma

NCT00636792

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Georgetown University Medical Center Washington D.C., District of Columbia, United States

MidDakota Clinic - Cancer Treatment and Research Center Bismarck, North Dakota, United States

View Trial Details

Completed

Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)

NCT00505232

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Hospital Marques de Valdecilla Santander, Cantabria, Spain

Hospital del Mar Barcelona, Catalonia, Spain

Hospital Clínico de Santiago de Compostela Santiago de Compostela, Galica, Spain

View all 16 locations

View Trial Details

Completed

The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

NCT01266668

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Chonbuk National University Hospital Jeonju, South Korea

View Trial Details

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan

NCT01479387

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Many Locations, Japan

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions